Healthcare Pharmaceutical Biotech

Jaguar Health Reports First Quarter 2026 Financials

May 20, 2026 4:40 PM

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today reported its consolidated first-quarter 2026 financial results. 2026 FIRST QUARTER COMPANY FINANCIAL RESULTS: License and Grant Revenue: Effective January 12, 2026, Jaguar entered a U.S. licensing agreement with Woodward Specialty, LLC ("Woodward"), an affiliate of privately held Future Pak, LLC ("Future Pak"). Under the terms of the agreement, Future Pak is now the exclusive...

Read more

Glidewell Selects 43 Dentists for 2026 Guiding Leaders Cohort

May 20, 2026 12:00 PM

Glidewell, America's foremost dental laboratory and longtime provider of world-class continuing education solutions, has selected 43 dentists for the 2026 cohort of Guiding Leaders, the company's six-month leadership and business development program for practicing dentists. Now in its sixth year, Guiding Leaders addresses the business, communication, and leadership skills that clinical training does not cover. The selection committee reviewed...

Read more

Emerging Growth Research Releases Q1:26 Quarterly Update on SBC Medical Group; Upgrades to Buy Rating and Increases Price Target to $10.00

May 20, 2026 10:15 AM

Emerging Growth Research today announced the release of its Q1:26 Quarterly Update Report on SBC Medical Group Holdings, Inc. (NASDAQ:SBC), upgrading the Company to a Buy rating and increasing its 12-month price target to $10.00 from $9.00, representing significant potential upside from the Company's recent share price of $2.89 as of May 19, 2026. The Quarterly Update highlights SBC's expectation for a return to revenue growth in 2026 following...

Read more

CNS Pharmaceuticals CEO, Rami Levin, Participates in Virtual Investor CEO Connect Segment Highlighting Company's Recent Strategic Transformation Progress

May 20, 2026 9:02 AM

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biotechnology company focused on building a pipeline of innovative therapies addressing significant unmet medical needs, today announced that it participated in a Virtual Investor CEO Connect Segment. As part of the segment, Rami Levin, President and Chief Executive Officer of CNS Pharmaceuticals, highlighted the Company's recent $22.5 million financing, including its strategic...

Read more

Jaguar Health to Hold Investor Webcast May 26 Regarding Q1 2026 Financials & Corporate Updates; Jaguar CEO Lisa Conte Presenting May 28 at Lytham Partners Spring 2026 Investor Conference

May 20, 2026 9:00 AM

Jaguar Health, Inc. (NASDAQ:JAGX) today announced that the company will conduct an investor webcast on Tuesday, May 26, 2026 at 8:30 a.m. Eastern to review first-quarter 2026 financials and provide corporate updates, and that Lisa Conte, Jaguar's founder, president and CEO, will present virtually on Thursday, May 28, 2026 at 10 a.m. Eastern at the Lytham Partners Spring 2026 Investor Conference. Participation Instructions for Jaguar Health...

Read more

Aetna Better Health(R) of Louisiana Collaborates With Goodr To Launch Mobile Food Market and Chronic Care Program

May 20, 2026 9:00 AM

Originally published on CVS Health Company Newsroom Aetna Better Health® of Louisiana, a CVS Health® company (NYSE:CVS), today announced a new collaboration with Goodr, a hunger and food waste solutions company, to address food insecurity and support chronic disease management across Louisiana. One in six people face food insecurity in Louisiana. Through a $400,000 investment, Aetna will work with Goodr to bring a Food is Medicine Mobile Market...

Read more

TRNR Reports Q1 2026 Results, Driven By 279% Revenue Growth; Confirms 2026 Pro Forma Revenue Guidance of More Than $30m

May 20, 2026 8:30 AM

Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the Wattbike, CLMBR, FORME and Ergatta brands, today announced financial results for its first quarter ended March 31, 2026. Q1 2026 Financial Highlights Q1 2026 revenue was $5.1 million, a 279% increase compared to $1.4 million in Q1 2025. Reported revenue reflects 21 days of Ergatta consolidation following the March 11, 2026...

Read more

Telomir Pharmaceuticals Reports Peer-Reviewed Publication of Telomir-Zn Data Demonstrating Improved Survival and Multiple Endpoint Benefits in Wilson's Disease

May 20, 2026 8:00 AM

Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir" or the "Company"), a clinical-stage biotechnology company developing small-molecule therapeutics targeting epigenetic and metabolic drivers of cancer and age-related disease, today announced the peer-reviewed publication of preclinical data showing that Telomir-Zn produced dose-dependent survival improvement across multiple endpoints in a Wilson's disease model, supporting the biological...

Read more

Revive Therapeutics Announces Strategic Expansion of Bucillamine Program Across Infectious Diseases, Defence and Biothreat Medical Countermeasures

May 20, 2026 7:45 AM

Revive Therapeutics Ltd. ("Revive" or the "Company") (OTCQB:RVVTF)(CSE:RVV)(FRANKFURT:31R), a life sciences company focused on infectious diseases and medical countermeasures, today announced its strategic expansion plan for bucillamine across infectious disease, defence and biothreat-related applications. Revive believes bucillamine represents a differentiated strategic asset with potential relevance across multiple high-need areas, including...

Read more

Avel eCare Highlights Virtual Health as a Long Term Workforce Strategy for Rural Health Transformation

May 20, 2026 7:18 AM

As healthcare organizations across the country continue facing workforce shortages, provider burnout, financial pressure, and increasing challenges recruiting clinicians to rural communities, healthcare leaders are searching for solutions that go beyond temporary staffing fixes and short term incentives. Avel eCare, the nation's leading Virtual Health System, is helping healthcare organizations reframe telemedicine not simply as a technology...

Read more

Zomedica's PulseVet System Repeats as Official Shock Wave of the United States Eventing Association

May 20, 2026 6:00 AM

Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering innovative point-of-care diagnostic and therapeutic products for equine and companion animals, today announced the renewal of its sponsorship agreement with the United States Eventing Association (USEA). With this partnership, PulseVet is again named as the "Official Shock Wave of the USEA", reinforcing the ongoing commitment of Zomedica to support...

Read more

Onco-Innovations Reports Continued Advancement of Key Materials Used in the Synthesis of its Active Pharmaceutical Ingredient for ONC010 Development Program

May 19, 2026 6:00 PM

Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce, further to its news release dated April 28, 2026, continued progress in the intermediate1 scale-up and process development activities for the A83 and B4 precursor components supporting the Company's lead oncology program, ONC010, a novel nanoparticle-formulated PNKP inhibitor currently advancing through IND-enabling...

Read more

Wellgistics Health Reports First Quarter 2026 Financials and Provides Business Update

May 19, 2026 4:10 PM

Wellgistics Health, Inc. (NASDAQ:WGRX), a health information technology company, integrating proprietary pharmacy dispensing optimization artificial intelligence (AI) platform EinsteinRx™ with licensed blockchain-enabled smart contract technology through PharmacyChain™, reported financial results for the first quarter ended March 31, 2026 and provided a second quarter 2026 business update from its President & Interim-CEO Prashant Patel, RPh....

Read more

Bulletin From Annual General Meeting in Senzime AB (publ)

May 19, 2026 12:20 PM

Senzime (STO:SEZI) (OTCQX:SNZZF) - The annual general meeting in Senzime AB (publ), corp. reg. no 556565-5734 (the "Company") was held on 19 May 2026 at the Company's premises on Verkstadsgatan 8, Uppsala, whereby the shareholders primarily resolved on the following matters. Annual report and results The annual general meeting adopted the income statement and the balance sheet for the financial year 2025 and resolved, in accordance with the...

Read more

DaVita Sets Bold 2030 Community Care Commitments After Exceeding Prior Five-Year ESG Goals

May 19, 2026 12:10 PM

DaVita announced its 2030 Community Care commitments, a new set of long-term goals, focused on improving patient outcomes, supporting the expansion of economic opportunity for teammates, and strengthening community and environmental resilience. The announcement follows the company achieving or exceeding the majority of its prior five-year environmental, social and governance (ESG) goals, reinforcing DaVita's track record of turning ambition into...

Read more

Sunshine Biopharma Inc. Announces Closing of up to $18.0 Million Public Offering

May 19, 2026 12:05 PM

Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and developing life‑saving medicines across oncology, antivirals, and other key therapeutic areas, today announced the closing of its previously announced public offering made on a reasonable best efforts basis with gross proceeds to the Company of approximately $6.0 million, before deducting placement agent fees and other offering expenses payable by the...

Read more

New Illinois Hospital Pricing Data Reveal Massive Markups and Wildly Different Charges for the Same Drugs

May 19, 2026 11:20 AM

A new analysis released today by 3 Axis Advisors, drawing on data from Patient Rights Advocates' hospital drug price finder, reveals striking disparities in what Illinois hospitals charge for the same prescription drugs - including critical cancer treatments. The research raises fresh questions about hospital pricing practices as state lawmakers consider legislation to expand the federal 340B drug discount program. "These numbers expose a...

Read more

AP Technologies Acquires Blueacre Technology, Adding Nitinol and Precision Laser Processing to Its Catheter Platform

May 19, 2026 10:00 AM

AP Technologies, a vertically integrated contract manufacturer of catheters and medical tubing, today announced the acquisition of Blueacre Technology, a Dundalk, Ireland specialist in laser micromachining and nitinol processing for the medical device industry. The acquisition establishes AP Technologies' first European operation in Ireland's medtech corridor, and extends its catheter platform into the laser-processed metallic components used in...

Read more

AcutePet Urgent Care Expands into Grove City, Bringing Same-Day Pet Care to Columbus Communities

May 19, 2026 9:50 AM

AcutePet Urgent Care is bringing its eighth location to Grove City, providing accessible, same-day veterinary care to pet families throughout south Columbus and surrounding communities. Conveniently located at 3612 Hoover Road near Stringtown Road and just minutes from Grove City Town Center, Target, Kroger, Mount Carmel Grove City, and Grove City High School. AcutePet will open to the public on Friday, May 22 at 10:00 a.m. and will be open...

Read more

Medical Care Technologies (OTC PINK:MDCE) Positions Its Next-Generation AI Strategy Amid Rapid Breakthroughs from NVIDIA and Anthropic

May 19, 2026 9:15 AM

Medical Care Technologies Inc. (OTC PINK:MDCE) ("MDCE" or the "Company"), an emerging artificial intelligence and imaging technology company, today announced a strategic evaluation of next-generation AI infrastructure and multimodal vision systems following major advancements from industry leaders NVIDIA and Anthropic that may materially accelerate the Company's AI commercialization roadmap. Recent breakthroughs in artificial intelligence have...

Read more